AMPERSAND CAPITAL PARTNERS
Ampersand is a middle market private equity firm that focuses on healthcare and industrial sectors.
AMPERSAND CAPITAL PARTNERS
Industry:
Angel Investment Finance Financial Services Health Care Venture Capital
Founded:
1988-01-01
Status:
Active
Contact:
781-239-0700
Total Funding:
18.83 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Euro Google Font API WordPress Google Analytics Google Maps Content Delivery Network IPv6
Similar Organizations
Correlation Ventures
Correlation Ventures finances early, seed, and later stage venture, and debt financing investments and is based in California.
General Catalyst
General Catalyst is a venture capital firm that provides early-stage and growth equity investments.
GSR Ventures
GSR Ventures focuses on early-stage technology companies developing AI-enabled technology.
Inovia Capital
Inovia Capital is a venture capital firm that partners with founders to build impactful and enduring global companies.
NewSpring
NewSpring Capital is focused on leveraging operational expertise and capital to build market leading companies.
Peregrine Systems
Peregrine Systems provides enterprise software worldwide. It offers information technology (IT) asset and service management software
Ribbit Capital
Ribbit Capital is a venture capital firm that invests in early-stage companies.
Sequoia Capital
Sequoia Capital is a VC firm that invests in startups in the energy, financial, enterprise, healthcare, internet, and mobile industries.
Speedinvest
Speedinvest is a venture capital fund investing in pre-seed, seed, and early-stage tech startups.
Sutter Hill Ventures
Sutter Hill Ventures primarily invests in technology-based start-ups.
Current Advisors List
Advisor
1985-01-01
Advisor
Advisor
2011-09-01
Current Employees Featured
Stuart Auerbach Senior Advisor @ Ampersand Capital Partners
Senior Advisor
1991-01-01
David Q. Anderson General Partner @ Ampersand Capital Partners
General Partner
2010-06-01
Patrick Walsh Operating Partner @ Ampersand Capital Partners
Operating Partner
2018-03-01
Laurence McCarthy Venture Partner @ Ampersand Capital Partners
Venture Partner
Julie F. Giles Senior Accountant @ Ampersand Capital Partners
Senior Accountant
2003-01-01
Trevor L. Wahlbrink Partner @ Ampersand Capital Partners
Partner
2012-04-01
David J. Parker General Partner @ Ampersand Capital Partners
General Partner
Richard A. Charpie Founder and Managing Partner @ Ampersand Capital Partners
Founder and Managing Partner
Todd Johnson Operating Partner @ Ampersand Capital Partners
Operating Partner
Loretta M. McClary Tax counsel @ Ampersand Capital Partners
Tax counsel
1998-01-01
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2024-03-19 | Biologos | Biologos acquired by Ampersand Capital Partners | N/A |
| 2024-03-13 | Specac | Specac acquired by Ampersand Capital Partners | N/A |
| 2022-09-28 | Iuvo | Iuvo acquired by Ampersand Capital Partners | N/A |
| 2022-08-30 | AcuraBio | AcuraBio acquired by Ampersand Capital Partners | N/A |
| 2022-08-25 | Phosphorex | Phosphorex acquired by Ampersand Capital Partners | N/A |
| 2021-07-01 | ProtaGene | ProtaGene acquired by Ampersand Capital Partners | 40 M USD |
| 2021-01-05 | Genezen Laboratories | Genezen Laboratories acquired by Ampersand Capital Partners | N/A |
| 2020-09-21 | ALPCO Diagnostics | ALPCO Diagnostics acquired by Ampersand Capital Partners | N/A |
| 2020-09-21 | GeneWerk | GeneWerk acquired by Ampersand Capital Partners | N/A |
| 2019-05-29 | Vibalogics | Vibalogics acquired by Ampersand Capital Partners | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2023-11-28 | Julius Clinical | Ampersand Capital Partners investment in Private Equity Round - Julius Clinical | N/A |
| 2023-11-20 | ProtaGene | Ampersand Capital Partners investment in Private Equity Round - ProtaGene | N/A |
| 2023-11-02 | Genezen | Ampersand Capital Partners investment in Venture Round - Genezen | 18.5 M USD |
| 2023-06-27 | Vernal Biosciences | Ampersand Capital Partners investment in Series A - Vernal Biosciences | 20 M USD |
| 2023-06-12 | NanoImaging Services | Ampersand Capital Partners investment in Private Equity Round - NanoImaging Services | N/A |
| 2022-06-23 | Sterling Medical Devices | Ampersand Capital Partners investment in Private Equity Round - Sterling Medical Devices | N/A |
| 2022-06-07 | AnaBios | Ampersand Capital Partners investment in Series C - AnaBios | 6.5 M USD |
| 2022-06-02 | Vernal Biosciences | Ampersand Capital Partners investment in Series A - Vernal Biosciences | 21 M USD |
| 2022-04-18 | Syft Technologies | Ampersand Capital Partners investment in Private Equity Round - Syft Technologies | N/A |
| 2022-03-01 | BioEcho Life Sciences | Ampersand Capital Partners investment in Private Equity Round - BioEcho Life Sciences | N/A |
More informations about "Ampersand Capital Partners"
Ampersand Capital Partners 2024 Year in Review
6 days ago Ampersand Capital Partners, founded in 1988, is a middle-market private equity firm with $3 billion of assets under management, dedicated to growth-oriented investments in the …See details»
Core Values | Ampersand
Founded in the late 1980s, Ampersand Capital Partners began investing in life sciences companies in the early 1990s. Today, Ampersand focuses exclusively on growth equity …See details»
Ampersand Capital Partners | GrowthCap
Founded in 1988, Ampersand Capital Partners is a middle-market private equity firm dedicated to growth-oriented investments in the healthcare sector with $3 billion of assets under …See details»
Ampersand Capital Partners - Crunchbase
Ampersand Capital Partners invests in early to late-stage biotechnology, healthcare, and pharmaceutical companies, focusing on North America, particularly in California and Vermont. Learn More. Similar Investments. CBD …See details»
Ampersand Capital Partners' Leadership Team Team - The Org
The leadership team at Ampersand Capital Partners has a long history of experience in the financial and accounting industries, as well as in venture capital and private equity. Many …See details»
Ampersand Capital Partners
ProtaGene, a leading global contract research organization (CRO) dedicated to advanced analytics for biologics and cell and gene therapies, today announced additional investment …See details»
Ampersand Capital Partners - Investments, Portfolio & Company …
Dec 4, 2024 Ampersand Capital Partners has made 7 diversity investments. Their most recent diversity investment was on Jun 12, 2023, when NanoImaging ... Blue Sky Biotech Blue Sky …See details»
Ampersand Capital Partners - Strategy - That's Nice
Ampersand Capital Partners, a PE firm with $3 Billion in assets under management, has spent three decades investing in life science companies. The team requested a more modern, fresh, …See details»
Portfolio - Ampersand Capital
Ampersand Capital Partners stands at the forefront of life sciences investments, where scientific innovation meets strategic investment acumen. Ampersand’s value extends beyond traditional investment models to active collaboration …See details»
Ampersand Capital Partners - The Org
Ampersand Capital Partners 0 followers Founded in 1988, Ampersand is a middle-market private equity firm with more than $2 billion of assets under management dedicated to growth-oriented investments in the healthcare sector.See details»
Ampersand Capital Partners Ranks #1 for Growth Capital Private …
May 16, 2024 Ampersand Capital Partners, founded in 1988, is a middle-market private equity firm with $3 billion of assets under management, dedicated to growth-oriented investments in …See details»
Ampersand Capital Partners Named a Top Private Equity Firm of …
Aug 21, 2024 Ampersand Capital Partners, founded in 1988, is a middle-market private equity firm with $3 billion of assets under management, dedicated to growth-oriented investments in …See details»
Ampersand Capital Partners - Private Equity List
Founded in 1988, Ampersand is a middle-market private equity firm with more than $2 billion of assets under management dedicated to growth-oriented investments in the healthcare sector …See details»
Our Team | Ampersand
Hidde Van Kerckhoven joined Ampersand Capital Partners in 2022. Prior to joining Ampersand, he was a member of the healthcare investment team at Gimv where he was actively involved …See details»
Ampersand (Private Equity) investment portfolio - PitchBook
Oct 23, 2024 Founded in 1988, Ampersand Capital Partners is a growth expansion investment firm based in Wellesley, Massachusetts. The firm prefers to invest in healthcare, laboratory …See details»
VIVEbiotech Secures Growth Investment from Ampersand Capital …
Dec 4, 2024 VIVEbiotech, a leading lentiviral vector Contract Development and Manufacturing Organization (CDMO), today announced a growth equity investment from Ampersand Capital …See details»
Investment Criteria - Ampersand Capital
Founded 35 years ago, Ampersand Capital Partners stands as one of America’s oldest private equity firms, boasting a legacy of success in the life sciences sector. With a robust portfolio of …See details»
Canyon Labs Announces Strategic Acquisition of iuvo BioScience’s …
23 hours ago About Ampersand Capital Partners. Founded in 1988, Ampersand Capital Partners is a middle market private equity firm with $3 billion of assets under management dedicated to …See details»
Ampersand Capital Partners Ranks #1 for Growth Capital Private …
May 16, 2024 Ampersand Capital Partners, founded in 1988, is a middle-market private equity firm with $3 billion of assets under management, dedicated to growth-oriented investments in …See details»
Canyon Labs Announces Strategic Acquisition of iuvo ... - BioSpace
9 hours ago With the backing of Ampersand Capital Partners, iuvo BioScience is poised to serve as an innovative global leader in ophthalmic clinical research. About Canyon Labs. Canyon …See details»